Clearline Capital »

BioMarin Pharmaceutical shares owned by Clearline Capital

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Clearline Capital from 13F filings

Historical chart of Clearline Capital investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Clearline Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $23M 320k 70.29

More positions owned by Clearline Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Amazon (AMZN)
Perrigo SHS (PRGO)
Alight Com Cl A (ALIT)
Golar Lng SHS (GLNG)
NVIDIA Corporation (NVDA)
Alibaba Group Hldg Sponsored Ads (BABA)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Tko Group Holdings Cl A (TKO)
Hewlett Packard Enterprise (HPE)
Etsy (ETSY)
Mediaalpha Cl A (MAX)
BioMarin Pharmaceutical (BMRN)
Endeavor Group Hldgs Cl A Com (EDR)
Masimo Corporation (MASI)

View all positions for Clearline Capital

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical